Vincent Bille

Founder & Partner

  • PhD in biochemistry, Post-doctorate research associate in bio-organic chemistry, Masters degree in Business Administration (Louvain School of Management, Belgium)
  • 19 years of senior leadership experience in the pharmaceutical contract manufacturing industry
  • 15+ years of independent consultancy services to bio/pharmaceutical companies outsourcing primary or secondary manufacturing activities
  • International, cross-cultural project and relationship management services
  • Long-term or project-based, part-time lean and pragmatic consultancy model, ranging all the way from spot, arms-length support to integrated management missions in Tech Ops, QA areas, Regulatory-CMC

2007-Present

Marble Pharma Consult SRL — Founder & Managing Partner

Advises clients on strategic and operational CMC matters, outsourced development and manufacturing, technical quality oversight, regulatory CMC preparation, contractor governance, troubleshooting, risk mitigation and complex international project execution.

Supports related strategic technical assessment in the context of due diligences related to M&A, divestment, right-sizing or new business developments and associated capital expenditure.

2006-2007

Lonza — Director, Sales & Business Development

Support of client portfolio integration following acquisition of UCB-Bioproducts activities, strengthening continuity of service, commercial transition, peptide project management and customer relationship management from the Cambridge, MA office.

1990-2006

UCB-Bioproducts — Senior Commercial, Business Unit and Operations Leadership Roles

Held senior leadership roles across commercial operations, business-unit management, customer service, development & technical operations and manufacturing, providing a strong client-side and supplier-side perspective for consulting engagements.

Led global bio/pharmaceutical client relationships, established the Cambridge, MA commercial office, managed North America and Australia commercial operations representing more than 85% of divisional sales, held P&L responsibility for approximately €45m in peptide and formulation activities, coordinated around 30 customer programs, supported greenfield construction of a $9m US customer application laboratory. Cambridge, MA-based General Manager of the US subsidiary reporting to the Board of Directors.

Developed the peptide department from a small non-GMP activity into a profitable, fully GMP-compliant world-class CMO with more than 350 employees, providing practical insight into building, scaling and improving regulated technical operations.